SCHEMBL14649657

SCHEMBL14649657

CCCCOc1ccc(C(=O)c2c(C)oc3ccc(N)cc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM7A Q6ZMT4 2/20 0.55
▸ MAPK1 P28482 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ CYP2C19 P33261 1/20 0.48
▸ SLC2A1 P11166 1/20 0.48
▸ LMNA P02545 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ ESR1 P03372 1/20 0.46
▸ PGR P06401 1/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ ADRA2A P08913 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ CHRM1 P11229 1/20 0.46
▸ DRD1 P21728 1/20 0.46
▸ TBXA2R P21731 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ PDE4A P27815 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15426085 0.95 KDM7A (0.53) KDM7AMAPK1HTTTDP1L3MBTL1
SCHEMBL9485662 0.93 ESR1 (0.56) SLC2A1ESR1PGRCHRM2HTR1A
SCHEMBL18696169 0.88 KDM7A (0.57) KDM7AMAPK1HTTTDP1L3MBTL1
SCHEMBL15426076 0.87 KDM7A (0.49) KDM7AMAPK1HTTTDP1L3MBTL1
SCHEMBL13890098 0.86 KDM5A (0.62) KDM7AESR1PGRCHRM2HTR1A
SCHEMBL15426103 0.83 KDM7A (0.55) KDM7AMAPK1HTTTDP1L3MBTL1
SCHEMBL13720923 0.83 KDM5A (0.58) KDM7AESR1PGRCHRM2HTR1A
SCHEMBL2501228 0.83 KDM5A (0.58) KDM7AESR1PGRCHRM2HTR1A
SCHEMBL16363116 0.82 RAD52 (0.52) KDM7AMAPK1HTTTDP1L3MBTL1
SCHEMBL2040079 0.82 ESR1 (0.59) KDM7AESR1PGRCHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130023677-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES SANOFI (FR) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023677-A1 PROCESS FOR PREPARING AMINOBENZOFURAN DERIVATIVES CYP2F1, F5, F12 KDM7A 1255/4885MAPK1 1749/4885HTT 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback